| Bioactivity | Thalidomide-azetidine-CHO is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide (HY-14658) based cereblon ligand and a linker used in PROTAC technology[1]. |
| CAS | 2416132-70-0 |
| Formula | C17H15N3O5 |
| Molar Mass | 341.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wuhan Humanwell Innovative Drug Research and Development Center Limited Company; Humanwell Healthcare (Group) Co., Ltd. Preparation of imidazopyridine compounds as IRAK4 degraders. China, CN117777126 A 2024-03-29 |
Thalidomide-azetidine-CHO
CAS: 2416132-70-0 F: C17H15N3O5 W: 341.32
Thalidomide-azetidine-CHOis a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide (HY-14658)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.